Prohormone brain natriuretic peptide (proBNP), BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients. Correlation with ventricular function, fluid removal and effect of hemodiafiltration

被引:47
作者
Bargnoux, Anne-Sophie [1 ]
Klouche, Kada [2 ]
Fareh, Jeanette [3 ]
Barazer, Isabelle [4 ]
Villard-Saussine, Sylvie [3 ]
Dupuy, Anne-Marie [1 ]
Leray-Moragues, Helene [5 ]
Giuliani, Isabelle [6 ]
Canaud, Bernard [5 ]
Cristol, Jean-Paul [1 ]
机构
[1] Univ Montpellier I, CHU Lapeyronie, Biochim Lab, Montpellier, France
[2] Univ Montpellier I, CHU Lapeyronie, Serv Reanimat Metabol, Montpellier, France
[3] FRE CNRS 3009, Montpellier, France
[4] CH, Biochim Lab, Beziers, France
[5] Univ Montpellier I, CHU Lapeyronie, Serv Nephrol Hemodialyse & Soins Intensifs, Montpellier, France
[6] Labs Bio Rad, Marnes La Coquette, France
关键词
brain natriuretic peptide (BNP); dialysis; hemodiafiltration; N-terminal proBNP; proBNP;
D O I
10.1515/CCLM.2008.192
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Brain natriuretic peptide (BNP), N-terminal proBNP (NT-proBNP) and to a lesser extent prohormone proBNP are recognized as biochemical markers of left ventricular dysfunction. In renal failure, interpretation of natriuretic peptide remains unclear, as natriuretic peptide levels may be not only be dependent on cardiac function and dimensions but also on renal function, fluid volume and removal by dialysis procedure including hemodiafiltration (HDF). The purpose of this study was (i) to assess BNP, NT-proBNP and proBNP levels and their correlation with clinical and echocardiographic data in chronic hemodialysis patients, and (ii) to investigate basal level alteration following HDF. Methods: Baseline clinical and echocardiographic parameters were collected in 31 dialysis patients without evidence of cardiac failure. Pre- and post-HDF BNP, NT-proBNP and proBNP concentrations were measured. Correlations between echocardiographic measurements and basal circulating peptides, between changes in peptide values and changes in fluid volume after HDF were investigated. Results: Baseline plasmatic levels were elevated (BNP = 517 +/- 840 pg/mL, NT-proBNP = 5340 +/- 6132 pg/mL and proBNP = 3569 +/- 4683 pg/mL) and correlated with left auricular diameter and left ventricular mass index. HDF session induced a significant decrease of 39%, 59% and 36% for BNP, NT-proBNP and proBNP levels, respectively. This decrease was not correlated to post-HDF fluid removal or weight decrease. Correlation between BNP and proBNP was stronger (r(2) = 0.88) than between NT-proBNP and proBNP (r(2) = 0.54). Conclusions: Despite their elimination, BNP, NT-proBNP and proBNP could be potential markers of left ventricular remodeling in chronic renal failure patients on hemodialysis. According to these results, their cut-off values, however, need to be re-evaluated.
引用
收藏
页码:1019 / 1024
页数:6
相关论文
共 22 条
[1]   Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death [J].
Apple, FS ;
Murakami, MM ;
Pearce, LA ;
Herzog, CA .
CLINICAL CHEMISTRY, 2004, 50 (12) :2279-2285
[2]  
DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205
[3]   ECHOCARDIOGRAPHIC DETERMINATION OF LEFT-VENTRICULAR MASS IN MAN - ANATOMIC VALIDATION OF METHOD [J].
DEVEREUX, RB ;
REICHEK, N .
CIRCULATION, 1977, 55 (04) :613-618
[4]   Association between brain natriuretic peptide and extracellular water in hemodialysis patients [J].
Fagugli, RM ;
Palumbo, B ;
Ricciardi, D ;
Pasini, P ;
Santirosi, P ;
Vecchi, L ;
Pasticci, F ;
Palumbo, R .
NEPHRON CLINICAL PRACTICE, 2003, 95 (02) :C60-C66
[5]  
FOLEY RN, 1995, J AM SOC NEPHROL, V5, P2024
[6]   Relationship between B-type natriuretic peptides and pulmonary capillary wedge pressure in the intensive care unit [J].
Forfia, PR ;
Watkins, SP ;
Rame, JE ;
Stewart, KJ ;
Shapiro, EP .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (10) :1667-1671
[7]   Assay for measurement of intact B-type natriuretic peptide prohormone in blood [J].
Giuliani, Isabelle ;
Rieunier, Francois ;
Larue, Catherine ;
Delagneau, Jean-Franois ;
Granier, Claude ;
Pau, Bernard ;
Ferriere, Marc ;
Saussine, Max ;
Cristol, Jean-Paul ;
Dupuy, Anne-Marie ;
Merigeon, Emmanuel ;
Merle, Delphine ;
Villard, Sylvie .
CLINICAL CHEMISTRY, 2006, 52 (06) :1054-1061
[8]   BNP and N-terminal proBNP are both extracted in the normal kidney [J].
Goetze, JP ;
Jensen, G ;
Moller, S ;
Bendtsen, F ;
Rehfeld, JF ;
Henriksen, JH .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 (01) :8-15
[9]   N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients [J].
Khan, Ijaz A. ;
Fink, Jeffrey ;
Nass, Caitlin ;
Chen, Hegang ;
Christenson, Robert ;
deFilippi, Christopher R. .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (10) :1530-1534
[10]   Beta2-microglobulin removal by extracorporeal renal replacement therapies [J].
Krieter, DH ;
Lemke, HD ;
Canaud, B ;
Wanner, C .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2005, 1753 (01) :146-153